BioCardia's CardiAMP HF Trial Echocardiography Data to be Presented at THT Meeting

BioCardia announced that echocardiography data from the CardiAMP HF trial will be presented at the Technology and Heart Failure Therapeutics (THT) Meeting. The presentation will be made by Dr. Amish Raval, a national co-principal investigator of the trial. The data is from the CardiAMP Cell Therapy for heart failure treatment and will be presented as a late-breaking clinical trial oral presentation.